OAKTREE CAPITAL MANAGEMENT LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 31 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$10,619,788
-48.3%
10,697,000
-49.0%
0.12%
-45.8%
Q4 2022$20,534,756
+9.1%
20,994,000
+8.4%
0.22%
+4.3%
Q3 2022$18,828,000
-4.4%
19,361,000
-5.4%
0.21%
-9.6%
Q2 2022$19,704,000
-0.9%
20,472,000
+0.6%
0.23%
+10.6%
Q1 2022$19,882,000
+6.4%
20,353,000
+9.0%
0.21%
+1.5%
Q4 2021$18,683,000
-7.4%
18,672,000
-6.8%
0.20%
-27.7%
Q3 2021$20,172,000
+9.8%
20,037,999
+8.6%
0.28%
+14.2%
Q2 2021$18,372,000
+15.5%
18,449,999
+20.9%
0.25%
+11.8%
Q1 2021$15,908,000
-0.1%
15,259,000
-9.2%
0.22%
-19.3%
Q4 2020$15,931,000
-6.0%
16,797,000
-9.8%
0.27%
-25.5%
Q3 2020$16,940,000
-2.9%
18,629,000
-6.0%
0.37%
-4.9%
Q2 2020$17,437,000
+11.6%
19,826,000
+5.1%
0.39%
-11.8%
Q1 2020$15,622,000
-24.5%
18,865,000
-21.1%
0.44%
+12.6%
Q4 2019$20,688,000
+61.0%
23,903,000
+55.5%
0.39%
+54.8%
Q3 2019$12,849,000
-24.5%
15,368,000
-21.8%
0.25%
-21.0%
Q2 2019$17,013,00019,648,0000.32%
Other shareholders

There were no reported owners of LIGAND PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of LIGAND PHARMACEUTICALS INC shareholders